Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2014, Vol. 41 Issue (5): 567-571    DOI: 10.12891/ceog17952014
Original Research Previous articles | Next articles
Sexual dysfunction in Turkish women with dyspareunia and its impact on the quality of life
B. Artunc Ulkumen1, M.M. Erkan1, H.G. Pala1, *(), Y. Bulbul Baytur1
1Obstetrics and Gynecology Department, Celal Bayar University School of Medicine, Manisa (Turkey)
Download:  PDF(63KB)  ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of Investigation: The authors aimed to determine the prevalence of female sexual dysfunction (FSD) among Turkish dyspareunic women and to establish the associated factors with FSD. Furthermore, they aimed to investigate if dyspareunia and possible associated sexual complaints were related to impaired quality of life (QoL). Materials and Methods: The study included 154 women admitted to the present gynecology department at a tertiary center in the west region of Turkey, 67 of which suffered from dyspareunia. The remaining 87 sexually healthy women were included in the control group. FSD was assessed with 19-item validated female sexual function index (FSFI). QoL was assessed using short form 36 (SF-36). The chi-squared test and t-test were used for analysing the group differences. Pearson’s correlation test was used to determine the effect of the variables of FSFI on the SF-36. Multivariance analysis and logistic regression was used to determine independent risk factors for FSD and to estimate odds ratio (OR) with 95% confidence interval (CI). Results: The incidence of FSD in dyspareunic group and control group was 86.57% and 36.8%, respectively (p < 0.001). Dyspareunic women had lower scores with regards to sexual desire, arousal, lubrication, orgasm, satisfaction, and pain domains at significant level (p < 0.001). Education level, time period after the last delivery, duration of marriage, parity, and dyspareunia were significantly related to FSD. However, dyspareunia was an independent risk factor for FSD (OR 11.49; 95% CI 4.95-26.67). Regarding the impact on the QoL, dyspareunic women had lower scores with regards to the physical role, social function, bodily pain, and vitality domains. Conclusion: The present results show that dyspareunia has a major impact on women’s sexual function and QoL. Clinicians have an important role for encouraging women to report their sexual complaints. Identifying dyspareunia and treating FSD may positively affect women’s sexual function and overall QoL.
Key words:  Dyspareunia      Female sexual dysfunction      FSD      FSFI      SF-36     
Published:  10 October 2014     
*Corresponding Author(s):  H.G. PALA     E-mail:  gursoypala@yahoo.com

Cite this article: 

B. Artunc Ulkumen, M.M. Erkan, H.G. Pala, Y. Bulbul Baytur. Sexual dysfunction in Turkish women with dyspareunia and its impact on the quality of life. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 567-571.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog17952014     OR     https://ceog.imrpress.com/EN/Y2014/V41/I5/567

[1] Gokcen Erdogan. Evaluation of satisfaction level of women with labiaplasty[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 918-923.
[2] Maria Aparecida Mazzutti Verlangieri Carmo, Helmer Herren, Francisco J. C. Dos-Reis, Fabricio Da Silva Costa, Julio C. Rosa-e-Silva, Antonio Alberto Nogueira, Omero Benedicto Poli-Neto. Reliability and agreement of three-dimensional/four-dimensional transperineal ultrasound in women with chronic pelvic pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 494-499.
[3] Banuhan Şahin, Görker Sel, Buğra Şahin, Şafak Hatırnaz. Comparison of sexual function scale scores in women according to the contraception method used as part of family planning strategy in Turkey[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 347-352.
[4] Ö. Koşar Can, Ö.T. Güler, Ü. Çabuş, D. Kılıç, C. Kabukçu. Evaluation of sexual functions and quality of life in female patients after hysterectomy for benign symptomatic diseases[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 693-700.
[5] M. C. Teodoro, G. Scibilia, E. Lomeo, B. Pecorino, A. Galia, P. Scollo. Carbon dioxide laser as a new valid treatment of lichen sclerosus[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 206-210.
[6] Ju-Qi Ma, Chun-Fen Guo, Ayshamgul Hasim. Clinical efficacy of levonorgestrel releasing intrauterine system for the treatment of adenomyosis in perimenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 387-390.
[7] G. Sukgen, A. Altunkol, D. Abat. Comparison between four- and six-arm pelvic organ polypropylene mesh implantation for the treatment of pelvic organ prolapse[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 414-418.
[8] M. Zu, W. Meng, Q.Z. Guo, Z.Q. Liu. Deep infiltrating endometriosis in young women[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 268-271.
[9] H. S. O. Abduljabbar, M. A. Alkasih, S. W. Khayat, R. M. Qotbi, M. T. Alkhatieb, A. H. Abduljabbar. Screening of sexual dysfunction in Saudi women before and after the age of 40 years[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 526-528.
[10] J.H. Check, R. Cohen. The triad of luteal phase ocular migraines, interstitial cystitis, and dyspareunia as a result of sympathetic nervous system hypofunction[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 575-577.
[11] P. De Franciscis, G. Mainini, E.M. Messalli, C. Trotta, A. Luisi, E. Laudando, G. Marino G. Della Puca, F.V. Cerreto, M. Torella. Arterial hypertension and female sexual dysfunction in postmenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2013, 40(1): 58-60.
[12] J.H. Check, R. Cohen. Chronic pelvic pain - traditional and novel therapies: Part II medical therapy[J]. Clinical and Experimental Obstetrics & Gynecology, 2011, 38(2): 113-118.
[13] J.H. Check. Chronic pelvic pain syndromes – traditional and novel therapies: Part I surgical therapy[J]. Clinical and Experimental Obstetrics & Gynecology, 2011, 38(1): 10-13.
No Suggested Reading articles found!